- Home
- SLAB vs PTGX Comparison
SLAB vs PTGX Comparison
Compare SLAB & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLAB
- PTGX
- Stock Information
- Founded
- SLAB 1996
- PTGX 2006
- Country
- SLAB United States
- PTGX United States
- Employees
- SLAB N/A
- PTGX N/A
- Industry
- SLAB Semiconductors
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- SLAB Technology
- PTGX Health Care
- Exchange
- SLAB Nasdaq
- PTGX Nasdaq
- Market Cap
- SLAB 4.7B
- PTGX 4.0B
- IPO Year
- SLAB 2000
- PTGX 2016
- Fundamental
- Price
- SLAB $136.54
- PTGX $77.57
- Analyst Decision
- SLAB Buy
- PTGX Strong Buy
- Analyst Count
- SLAB 11
- PTGX 8
- Target Price
- SLAB $144.00
- PTGX $74.13
- AVG Volume (30 Days)
- SLAB 240.6K
- PTGX 1.6M
- Earning Date
- SLAB 11-04-2025
- PTGX 11-06-2025
- Dividend Yield
- SLAB N/A
- PTGX N/A
- EPS Growth
- SLAB N/A
- PTGX N/A
- EPS
- SLAB N/A
- PTGX 0.80
- Revenue
- SLAB $703,203,000.00
- PTGX $209,180,000.00
- Revenue This Year
- SLAB $37.61
- PTGX N/A
- Revenue Next Year
- SLAB $19.17
- PTGX $243.08
- P/E Ratio
- SLAB N/A
- PTGX $96.33
- Revenue Growth
- SLAB 29.66
- PTGX N/A
- 52 Week Low
- SLAB $82.82
- PTGX $33.31
- 52 Week High
- SLAB $160.00
- PTGX $93.25
- Technical
- Relative Strength Index (RSI)
- SLAB 54.35
- PTGX 63.15
- Support Level
- SLAB $125.14
- PTGX $74.62
- Resistance Level
- SLAB $138.94
- PTGX $93.25
- Average True Range (ATR)
- SLAB 4.55
- PTGX 4.76
- MACD
- SLAB 0.65
- PTGX 0.80
- Stochastic Oscillator
- SLAB 85.36
- PTGX 49.44
About SLAB Silicon Laboratories Inc.
Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.